Filing Details
- Accession Number:
- 0001104659-21-072618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-26 21:28:23
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-26 21:28:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1472012 | Immunome Inc. | IMNM | Pharmaceutical Preparations (2834) | 770694340 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1826833 | D Purnanand Sarma | C/O Immunome, Inc. 665 Stockton Drive, Suite 300 Exton PA 19341 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-25 | 10,500 | $18.41 | 10,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.38 to $18.52, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.